Browse the site

Start with a goal 40 things people take supplements for — sleep, stress, joints, focus.
Home Get the app
Cannabinoids

Cannabinoids

Best for

Feel less pain

Likely benefit 4–7 weeks 7 meta-analyses, n=28.7k #5 of 50 studied

  • 23 papers
  • 12 of 46 outcomes
  • 5 positive

Cannabinoids likely benefit adults with persistent pain, while evidence across sleep, anxiety, appetite, and other outcomes is less convincing and does not support broad everyday use.

Median effective dose, most-studied outcomes

  • Approach meals with more interest 4.62 mg 4–8 wk
Full protocol, 8 outcomes

Risk, worst reported severity

  • weight gain
  • sedation
All 4 events and interactions

What cannabinoids actually does

Outcome Effect Evidence Dose Time Rank
Clear benefits 1
Feel less pain Likely benefit Pain relief can make it easier to move, rest, focus, and get through the day.
moderate 		7 meta-analyses 8 papers · n=29k — 4–7 wk #5 /50
Modest benefits 3
Sleep that feels more restorative Likely real but unnoticeable Sleep quality reflects whether the night leaves you feeling well rested.
trivial 		3 meta-analyses 5 papers · n=5.1k 109 mg 1–7 wk —
Less nausea and vomiting with chemotherapy Likely real but unnoticeable Nausea, vomiting, and appetite loss can make it hard to eat and drink during chemotherapy.
trivial 		2 meta-analyses 2 papers · n=2.4k — 0 wk #1 /2
Less nausea and vomiting Likely real but unnoticeable Nausea is the unsettled feeling that can come before vomiting or make food hard to face.
trivial 		3 meta-analyses 3 papers · n=1.5k — 0–6 wk #3 /9
Early research 4
Stay asleep through the night Faint early signal Uninterrupted sleep helps the night feel more settled and restorative.
small 		1 RCT 1 papers · n=40 109 mg 1 wk #8 /15
Feel less stressed day to day Not enough research Daily stress is the sense that life's demands are stretching beyond what you can handle.
trivial 		1 RCT 1 papers · n=40 109 mg 1 wk —
Fall asleep sooner Not enough research A shorter wait for sleep can make bedtime feel less frustrating.
trivial 		1 RCT 1 papers · n=40 109 mg 1 wk —
Get more sleep each night Not enough research More time asleep can help you meet the amount of sleep you need.
trivial 		1 RCT 1 papers · n=40 109 mg 1 wk —
Doesn't appear to help 4
Reduce insomnia symptoms Doesn't appear to help Less severe insomnia can mean fewer nights spent struggling with sleep.
trivial 		1 meta-analysis 2 papers · n=21k 109 mg 1 wk —
Move more comfortably with MS Probably doesn't help Comfortable mobility can make getting around with multiple sclerosis less limiting.
trivial 		1 meta-analysis 1 papers · n=3.2k — — —
Feel more like eating when appetite is low Probably doesn't help Appetite shapes how much you want to eat and how enjoyable food feels.
trivial 		4 meta-analyses 5 papers · n=2.2k 2.5–6.16 mg 4–8 wk —
Feel less anxious Probably doesn't help Anxiety can bring persistent worry, unease, and physical tension into ordinary moments.
trivial 		2 meta-analyses 3 papers · n=1.1k 109 mg 1 wk —

Effect tiers come from native-unit MCID where available, Cohen's d otherwise.

Protocol

Dose, timing & forms

How much

The strongest signal in the reviewed evidence is for pain, with studies generally assessing outcomes after about 4 weeks, and some extending to roughly 7 weeks.12 Sleep and anxiety trials used an oral cannabinoid product reported at 109 mg, but they did not show meaningful improvement in insomnia or baseline anxiety, so that figure is not a reliable target dose.1 Sublingual appetite studies used 2.5 to 6.16 mg, yet appetite itself did not improve meaningfully.1

When and how long

Use the timing from the exact product and clinical protocol, not a generic “cannabinoid” rule. The sleep and anxiety studies used daily oral dosing over about 10 days, while pain outcomes were assessed over several weeks.1 Sedation is a known concern, so do not first test a cannabinoid product before driving, work requiring sharp attention, or other safety-sensitive activities.12

Forms & standardisation

Product identity is the key detail. Look for the exact cannabinoid ingredients and amount per dose, especially whether a product contains CBD, THC, or a THC-like prescription cannabinoid, because these are not interchangeable in trials.1 Avoid assuming that a broad-spectrum or full-spectrum label matches a studied formula. The reviewed pain, nausea, sleep, and appetite research used different products and routes.13

Studied range, by outcome

Outcome Studied range Median effective Duration Evidence
Sleep more soundly 109 mg — 1–7 wk 5 papers
Approach meals with more interest 2.5–6.16 mg 4.62 mg 4–8 wk 5 papers 1 sig. endpoint
Ease anxiety symptoms 109 mg — 1 wk 3 papers
Sleep more easily through the night 109 mg — 1 wk 2 papers
Handle daily demands with less stress 109 mg — 1 wk 1 paper
Stay asleep through the night 109 mg — 1 wk 1 paper
Fall asleep sooner 109 mg — 1 wk 1 paper
Spend more time asleep 109 mg — 1 wk 1 paper

Adverse events and drug interactions

Safety events

weight gain
sedation
extrapyramidal symptoms
any adverse event (increased overall)
Buy well

Recommended Cannabinoids products

Real products that dose Cannabinoids where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.

Chosen for adequate Cannabinoids dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.

In context

What this is and how it works

  • Across 8 studies (n=28,747), cannabinoids improved pain-related outcomes across 22 endpoints, with direction consistently favoring benefit.1
  • Twenty-three papers reviewed here span 46 outcomes, including pain, sleep, anxiety, appetite, nausea, and chemotherapy-related vomiting.
  • Benefits depend on cannabinoid formulation, dose, and population, with sedation and other adverse effects remaining important trade-offs.

Cannabinoids are a family of compounds found in cannabis and also made in laboratories. Products differ hugely: some contain CBD, some contain THC-like compounds, and some combine several cannabinoids. That difference matters because a result from one product does not automatically apply to another.1

Cannabinoids plug into the body's cannabinoid signaling system, a set of chemical dimmer switches that adjusts how strongly nerves pass along pain, nausea, appetite, and alertness signals.1 THC-like compounds more directly stimulate brain cannabinoid receptors, which helps explain both their symptom effects and risks such as sedation and unwanted movement effects.1

Bottom line

Cannabinoids are most worth discussing with a qualified clinician when pain remains a meaningful problem and you can weigh a moderate possible benefit against sedation, weight gain, and other adverse effects.12 They are not a strong bet for everyday anxiety, insomnia, or appetite based on these findings. Choose a product only when its exact ingredients and dose are clear.

Frequently asked

Common questions

Do cannabinoids help with pain?

The reviewed trials show a moderate benefit for general pain, although results differ by the type of pain and the cannabinoid product used. Side effects matter, so this is not a casual choice for everyone.12

Do cannabinoids improve sleep?

They do not appear to improve insomnia burden or sleep medicine use. Some studies found tiny changes in sleep quality, but those changes were unlikely to feel noticeable in daily life.1

Do cannabinoids reduce anxiety?

The reviewed oral-product trials did not show a meaningful reduction in baseline anxiety. That finding does not support using these products as a reliable everyday anxiety supplement.1

What is the difference between CBD and THC?

CBD and THC are different cannabinoids with different effects and safety profiles. A label that only says “cannabinoids” leaves out information you need to interpret both the evidence and the product's likely effects.

Sources

Sources

  1. 1. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (2015) ↑
  2. 2. Cannabis-based medicines for chronic neuropathic pain in adults (2018) ↑
  3. 3. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (2015) ↑

Generated August 27, 2026

Related

More evidence for Cannabinoids